Operative management in patients with upper tract urothelial carcinoma in Iceland: a population-based study

References

• Rouprêt M, Babjuk M, Burger M, et al. European association of urology guidelines on upper urinary tract Urothelial Carcinoma: 2020 update. Eur Urol. 2021;79(1):62–79.
   PubMed Web of Science ®Google Scholar
• Margulis V, Shariat SF, Matin SF, et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 2009;115(6):1224–1233.
   PubMed Web of Science ®Google Scholar
• Seisen T, Peyronnet B, Dominguez-Escrig JL, et al. Oncologic outcomes of kidney-sparing surgery Versus radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the EAU non-muscle invasive bladder cancer guidelines panel. Eur Urol. 2016;70(6):1052–1068.
   PubMed Web of Science ®Google Scholar
• Mostofi FK, Sobin LH, Torloni H. Histologic typing of urinary bladder tumors. International histological classification of tumors, No. 10. Geneva, Switzerland: World Health Organization; 1973.
   Google Scholar
• Moch H, Humphrey PA, Ulbright TM, et al. WHO classification of tumours of the urinary system and male genital organs. 4th ed. Vol. 8. Geneva, Switzerland: World Health Organization; 2016.
   Google Scholar
• Guðbjartsson T, Einarsson GV, Jacobsen E, et al. Krabbamein í nýrnaskjóðu og þvagleiðurum: afturskyggn klínísk rannsókn. Laeknablaðið. 1994;80:115–123.
   Google Scholar
• Inman BA, Tran VT, Fradet Y, et al. Carcinoma of the upper urinary tract: predictors of survival and competing causes of mortality. Cancer. 2009;115(13):2853–2862.
   PubMed Web of Science ®Google Scholar
• Novara G, De Marco V, Gottardo F, et al. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers. Cancer. 2007;110(8):1715–1722.
   PubMed Web of Science ®Google Scholar
• Lughezzani G, Burger M, Margulis V, et al. Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol. 2012;62(1):100–114.
   PubMed Web of Science ®Google Scholar
• Rouprêt M, Hupertan V, Seisen T, et al. Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis. J Urol. 2013;189(5):1662–1669.
   PubMed Web of Science ®Google Scholar
• Hurel S, Rouprêt M, Seisen T, et al. Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomy. World J Urol. 2015;33(3):335–341.
   PubMed Web of Science ®Google Scholar
• Azawi NH, Naeraa SH, Subhi Y, et al. Oncological outcomes of radical nephroureterectomy for upper urinary tract urothelial neoplasia in Denmark. Scand J Urol. 2020;54(1):58–64.
   PubMed Web of Science ®Google Scholar
• O’Brien T, Ray E, Singh R, et al. Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial). Eur Urol. 2011;60(4):703–710.
   PubMed Web of Science ®Google Scholar
• Fang D, Li XS, Xiong GY, et al. Prophylactic intravesical chemotherapy to prevent bladder tumors after nephroureterectomy for primary upper urinary tract urothelial carcinomas: a systematic review and meta-analysis. Urol Int. 2013;91(3):291–296.
   PubMed Web of Science ®Google Scholar
• Ito A, Shintaku I, Satoh M, et al. Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP monotherapy study group trial. J Clin Oncol. 2013;31(11):1422–1427.
   PubMed Web of Science ®Google Scholar
• Habuchi T. Origin of multifocal carcinomas of the bladder and upper urinary tract: molecular analysis and clinical implications. Int J Urol. 2005;12(8):709–716.
   PubMed Web of Science ®Google Scholar
• van Doeveren T, van de Werken HJG, van Riet J, et al. Synchronous and metachronous urothelial carcinoma of the upper urinary tract and the bladder: are they clonally related? A systematic review. Urol Oncol. 2020;38(6):590–598.
   PubMed Web of Science ®Google Scholar
• Baboudjian M, Al-Balushi K, Michel F, et al. Diagnostic ureteroscopy prior to nephroureterectomy for urothelial carcinoma is associated with a high risk of bladder recurrence despite technical precautions to avoid tumor spillage. World J Urol. 2020;38(1):159–165.
   PubMed Web of Science ®Google Scholar
• Xylinas E, Kluth L, Passoni N, et al. Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool. Eur Urol. 2014;65(3):650–658.
   PubMed Web of Science ®Google Scholar
• Inamoto T, Matsuyama H, Komura K, et al. Tumor location based segmentation in upper-tract urothelial carcinoma impacts on the urothelial recurrence-free survival: a multi-institutional database study. Curr Urol. 2020;14(4):183–190.
   PubMedGoogle Scholar
• Chen CS, Li JR, Wang SS, et al. Tumor multifocality is a significant risk factor of urinary bladder recurrence after nephroureterectomy in patients with upper tract urothelial carcinoma: a single-institutional study. Diagnostics. 2020;10(4):201.
   Web of Science ®Google Scholar
• Rassweiler JJ, Schulze M, Marrero R, et al. Laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: is it better than open surgery? Eur Urol. 2004;46(6):690–697.
   PubMed Web of Science ®Google Scholar
• Ni S, Tao W, Chen Q, et al. Laparoscopic versus open nephroureterectomy for the treatment of upper urinary tract urothelial carcinoma: a systematic review and cumulative analysis of comparative studies. Eur Urol. 2012;61(6):1142–1153.
   PubMed Web of Science ®Google Scholar